表皮生长因子受体的免疫组合化学表达:在HER2阳性乳腺癌中具有预后价值
Yoldez Houcine1,2, Hend Ben Salem2, Sirine El Fekih1
1Immuno-histo-cytology department, Salah Azaiz Institute, Tunis, Tunisia.
Journal of immunoassay & immunochemistry
|March 10, 2025
概括
在HER2阳性乳腺癌中表达表皮生长因子受体 (EGFR) 与年轻患者和缺少淋巴血管入侵有关. 这一发现可能表明乳腺癌患者化疗反应的预测价值.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 分子生物学分子生物学
背景情况:
- 皮表皮生长因子受体 (EGFR) 表达在人类皮表皮生长因子受体2 (HER2) 阳性乳腺癌中未得到研究.
- 了解EGFR在HER2阳性乳腺癌中的作用对于治疗策略至关重要.
研究的目的:
- 为了确定EGFR免疫组织化学表达在HER2阳性乳腺癌中的患病率.
- 在这个患者队列中,将EGFR表达与各种临床解剖学参数相关联.
主要方法:
- 对HER2阳性乳腺癌病例 (2018-2020) 的回顾性分析.
- 使用抗EGFR单克隆抗体进行免疫组织化学评估.
- 阳性EGFR表达定义为整体得分≥1+.
主要成果:
- 这项研究包括50名患者.
- 在50岁以下的患者中,EGFR表达更频繁,并且与没有淋巴血管侵入有关.
- 多变量分析证实年轻,没有淋巴血管侵袭,高Ki67 (>60%) 作为EGFR阳性表达的独立预测因素.
结论:
- 这项研究是突尼斯首次研究HER2阳性乳腺癌中的EGFR表达.
- EGFR免疫组织化学表达与年轻的年龄,缺乏淋巴血管入侵和高Ki67.7有关.
- 这些关联表明EGFR可能作为HER2-阳性乳腺癌中化疗反应的预测标志物.
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


